Journal Title
PHYTOMEDICINE

PHYTOMEDICINE

ISSN / eISSN
0944-7113 / 1618-095X
Aims and Scope
Phytomedicine is primarily a therapy-oriented Journal. Phytomedicine publishes innovative studies on efficacy, safety, quality and mechanisms of action of specified plant extracts, phytopharmaceuticals and their isolated constituents. This includes clinical, pharmacological, pharmacokinetic, and toxicological studies of specified herbal medicinal products, herbal preparations and purified compounds which have a defined and consistent quality assuring reproducible pharmacological activity.

Phytomedicine was founded in 1994 to focus and stimulate research in this particular field and to set internationally accepted scientific standards for pharmacological studies, proof of clinical efficacy and safety of phytomedicines.
Subject Area

CHEMISTRY, MEDICINAL

INTEGRATIVE & COMPLEMENTARY MEDICINE

PHARMACOLOGY & PHARMACY

CiteScore
10.40 View Trend
CiteScore Ranking
Category Quartile Rank
Medicine - Complementary and Alternative Medicine Q1 #1/97
Medicine - Pharmaceutical Science Q1 #14/171
Medicine - Pharmacology Q1 #30/301
Medicine - Drug Discovery Q1 #19/156
Medicine - Molecular Medicine Q1 #30/171
Web of Science Core Collection
Science Citation Index Expanded (SCIE) Social Sciences Citation Index (SSCI)
Indexed -
Category (Journal Citation Reports 2023) Quartile
CHEMISTRY, MEDICINAL - SCIE Q1
INTEGRATIVE & COMPLEMENTARY MEDICINE - SCIE Q1
PHARMACOLOGY & PHARMACY - SCIE Q1
PLANT SCIENCES - SCIE Q1
H-index
105
Country/Area of Publication
GERMANY
Publisher
Urban und Fischer Verlag Jena
Publication Frequency
Bimonthly
Year Publication Started
1994
Annual Article Volume
677
Open Access
NO
Contact
ELSEVIER GMBH, URBAN & FISCHER VERLAG, OFFICE JENA, P O BOX 100537, JENA, GERMANY, 07705
Verified Reviews
Note: Verified reviews are sourced from across review platforms and social media globally.
After submitting the manuscript, it was returned for revision three times. After a successful submission, I waited for a week and the editor changed from the chief editor to the associate editor. Then it was sent for review. After a month, I received the revision comments. There were a total of three reviewers, with two of them raising questions about the writing aspect and one reviewer asking why only iron death was studied and not apoptosis, giving me 20 days to make revisions. After carefully revising the article according to the feedback, I submitted the revised manuscript approximately three weeks later. I thought that such minor revisions would be accepted directly, but to my surprise, I had to wait for another week for it to be sent for review again. This time, only one reviewer agreed to review it. After waiting for two weeks, I received the review comments. The other two reviewers still did not agree to review it. So, I sent an email to inquire about the situation and it took another week for it to be back in the editor's hands. They invited a new reviewer. After receiving the feedback from this new reviewer (who pointed out the need for some additional experiments), I waited for approximately one week and received a rejection letter stating that the journal requires positive controls and concentration gradients for in vitro and in vivo experiments. I checked previous articles published by the journal and found that some of them did not include positive controls and concentration gradients. It is frustrating that after three rounds of external review, the manuscript was rejected for this reason.
2022-11-22
Posted on 2022.4.25, received first-round comments on 2022.5.21, but due to work reasons, there was a delay. Revised the first round on 2022.6.29, second-round revision on 2022.7.4, and accepted on 2022.7.10. The process was quite fast (except for one reviewer who asked repeated questions...). There were six reviewers (possibly eight if invited?), and this journal has a feature where all manuscripts need to be reviewed by the editor-in-chief before being passed on to other relevant editors. There are many reviewers involved. Another thing about this journal is that even if one reviewer gives a rejection, if the overall opinion is for revisions, you still have the opportunity to respond to the reviewer who rejected your paper and convince them to change their decision to acceptance.
2022-07-10

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started